PLI Scheme for Bulk Drugs for Resilient Pharmaceutical Supply Chain

PLI Scheme for Bulk Drugs for Resilient Pharmaceutical Supply Chain: -A PIB FEATURE- The Production Linked Incentive (PLI) Scheme for Bulk Drugs is strengthening India’s domestic capabilities in manufacturing critical Key Starting Materials (KSMs), Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs), reducing import dependence and enhancing resilience across the pharmaceutical supply chain. Five Greenfield projects that have commissioned manufacturing facilities under the Scheme demonstrate